1-9 of 9
Alfonso Quintás-Cardama, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Biphenotypic Blast Phase (B-BP) of Chronic Myeloid Leukemia (CML): A Single Institution Experience

Hady Ghanem, MD, Hagop M. Kantarjian, MD, Elias Jabbour, Lakshmikanth Katragadda, MD, Jorge E. Cortes, MD, Naveen Pemmaraju, M.D., Alfonso Quintás-Cardama, M.D.
Journal: Blood
Blood (2012) 120 (21): 1687.
https://doi.org/10.1182/blood.V120.21.1687.1687
Published: 2012
Journal Articles

Dynamics and Prognostic Impact of Peripheral Blood Blast Clearance in Patients with Acute Myeloid Leukemia (AML) Receiving FLT3 Inhibitor Therapy in Combination with Induction Chemotherapy

Christopher B. Benton, MD, Peng Qiu, PhD, Farhad Ravandi, MD, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD, Sherry A. Pierce, RN, BS, Anisha Borthakur, Marina Konopleva, MD, PhD, Jorge E. Cortes, MD, Michael Andreeff, MD, PhD, Alfonso Quintás-Cardama, M.D.
Journal: Blood
Blood (2012) 120 (21): 1417.
https://doi.org/10.1182/blood.V120.21.1417.1417
Published: 2012
Journal Articles

Refined MD Anderson Prognostic Scoring System (MDAPS-R) for Chronic Myelomonocytic Leukemia (CMML)

Koichi Takahashi, MD, Naveen Pemmaraju, M.D., Miloslav Beran, Alfonso Quintás-Cardama, M.D., Jorge E. Cortes, MD, Farhad Ravandi, MD, Stefan Faderl, MD, Srdan Verstovsek, MD, PhD, Tapan M. Kadia, M.D., Gautam Borthakur, M.D., Elias J. Jabbour, MD, Naval Daver, MD, Zeev Estrov, MD, PhD, Sherry A. Pierce, RN, BS, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2012) 120 (21): 3797.
https://doi.org/10.1182/blood.V120.21.3797.3797
Published: 2012
Journal Articles

Disease Patterns for Patients (pts) with Chronic Myeloid Leukemia (CML) That Have BCR-ABL Transcript Levels > 10% At 3 Month of Therapy with Tyrosine Kinase Inhibitors (TKIs)

Aziz Nazha, Hagop M. Kantarjian, MD, Preetesh Jain, MD, DM, PhD, Elias J. Jabbour, MD, Alfonso Quintás-Cardama, M.D., Rajyalakshmi Luthra, PhD, Lynne V. Abruzzo, MD, PhD, Gautam Borthakur, M.D., Farhad Ravandi, MD, Sherry A. Pierce, RN, BS, Susan O'Brien, MD, Jorge E. Cortes, MD
Journal: Blood
Blood (2012) 120 (21): 3757.
https://doi.org/10.1182/blood.V120.21.3757.3757
Published: 2012
Journal Articles

Very High Rates of Clinical and Cytogenetic Response with the Combination of the Histone Deacetylase Inhibitor Pracinostat (SB939) and 5-Azacitidine in High-Risk Myelodysplastic Syndrome

Alfonso Quintás-Cardama, M.D., Hagop M. Kantarjian, MD, Farhad Ravandi, Cielo Foudray, Naveen Pemmaraju, Tapan M. Kadia, M.D., Gautam Borthakur, M.D., Naval G. Daver, MD, Stefan Faderl, MD, Elias Jabbour, Jorge E. Cortes, MD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2012) 120 (21): 3821.
https://doi.org/10.1182/blood.V120.21.3821.3821
Published: 2012
Journal Articles

Response to Frontline Therapy with Second Generation Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: Analysis of Outcome for b3a2 Vs. b2a2 Fusion Transcripts

Carlos G. Romo, M.D., Hagop M Kantarjian, M.D., Rajyalakshmi Luthra, Ph.D., Alfonso Quintás-Cardama, M.D., Elias J. Jabbour, MD, Gautam Borthakur, M.D., Tapan M. Kadia, M.D., Farhad Ravandi, MD, Naveen Pemmaraju, M.D., Sherry A. Pierce, RN, BS, Susan O'Brien, M.D., Jorge E. Cortes, MD
Journal: Blood
Blood (2012) 120 (21): 3781.
https://doi.org/10.1182/blood.V120.21.3781.3781
Published: 2012
Journal Articles

Prognostic Factors in the Blastic and Accelerated Phase of Patients with Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era

Young Kwang Chae, MD, MPH, Hagop M. Kantarjian, MD, Carlos G. Romo, M.D., Clay Whitaker, Elias J. Jabbour, MD, Susan O'Brien, M.D., Gautam Borthakur, M.D., Farhad Ravandi, MD, Deborah A. Thomas, MD, Sherry A. Pierce, RN, BS, Alfonso Quintás-Cardama, M.D., Jorge E. Cortes, MD
Journal: Blood
Blood (2012) 120 (21): 3786.
https://doi.org/10.1182/blood.V120.21.3786.3786
Published: 2012
Journal Articles

Natural History and Potential for Cure of Patients with Chronic Myeloid Leukemia in Chronic Phase Receiving Frontline Therapy with Recombinant Interferon-Alfa: 30-Year Update From M.D. Anderson Cancer Center

Alfonso Quintás-Cardama, M.D., Hagop M. Kantarjian, MD, Susan O'Brien, M.D., Elias J. Jabbour, MD, Guillermo Garcia-Manero, MD, Charles Koller, MD, Sherry A. Pierce, RN, BS, Moshe Talpaz, MD, Jorge E. Cortes, MD
Journal: Blood
Blood (2012) 120 (21): 918.
https://doi.org/10.1182/blood.V120.21.918.918
Published: 2012
Journal Articles

Nomogram to Prognosticate Outcomes in Patients with Chronic Myeloid Leukemia At Any Time-Point During Tyrosine Kinase Inhibitor Therapy

Alfonso Quintás-Cardama, M.D., Xuelin Huang, PhD, Sangbum Choi, PhD, Hagop M Kantarjian, M.D., Jorge E. Cortes, MD
Journal: Blood
Blood (2012) 120 (21): 71.
https://doi.org/10.1182/blood.V120.21.71.71
Published: 2012